Allogene Therapeutics Inc (NASDAQ:ALLO)

29.54
Delayed Data
As of Dec 05
 +0.06 / +0.20%
Today’s Change
23.37
Today|||52-Week Range
33.80
+9.69%
Year-to-Date
No recent news for Allogene Therapeutics Inc.

Today’s Trading

Previous close29.48
Today’s open29.63
Day’s range28.98 - 29.95
Volume750,735
Average volume (3 months)418,297
Market cap$3.4B
Data as of 4:00pm ET, 12/05/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+74.13%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.85

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics-0.44-2.14%
BPMCBlueprint Medicines ...-0.54-0.72%
IMMUImmunomedics Inc+0.49+2.72%
IOVAIovance Biotherapeut...+0.16+0.65%
Data as of 4:15pm ET, 12/05/2019

Financials

Next reporting dateMarch 6, 2020
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$0.00
Annual profit (last year)-$211.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts